genprowebdirectory
GEN Edge
News
Insights
Trends for 2021
Trends for 2020
A-Lists
Topics
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Magazine
Current Issue
Past Issues
Supplements
Subscribe
Resources
All
GEN Live
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Advertising
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Webinar Sponsorship
eBook Advertising
Email Nurture Campaigns
Ad Terms and Conditions
About GEN
Contact GEN
Create a Free Account
Get GEN Edge
Log In
GEN – Genetic Engineering and Biotechnology News
Mary Ann Liebert, Inc. Publishers
GEN Edge
Gene Therapy
OXGENE Eyes Further Growth in Cell and Gene Therapy Services after…
Coronavirus
Breathe In: Theravance Reports Positive Phase II Data for JAK Inhibitor
Cancer
The Life Oncolytic, with Stephen Russell
Synthetic Biology
Flush with Cash, Foresite Aims to Live Up to Its Name
OMICs
From Genomes to Drugs: An Interview with Vertex CSO David Altshuler
News
March 2021 Vol. 41 No. 3
A High-Content View to Cancer Immunotherapy Improvements
Cancer
Immunotherapy Boost May Come from Dendritic Cell Factories
News
New Insights into Ancient Gatekeeper Protein Complex
Imaging analysis
Study of Human Brain Images Generates New Insights into the Neurobiology…
Drug Discovery
Researchers Engineer E. coli for Animal-Free Drug Manufacturing
Insights
All
Trends for 2021
Trends for 2020
Infectious Diseases
SARS-CoV-2 Under Surveillance
Cancer
Immune Cell Profiles Reveal Cancer’s Leading Indicators
Translational Medicine
Animal Models Offer Improved Translatability
OMICs
Genomic Medicine Stands on the Shoulders of Giants
A-Lists
A-Lists
Top 7 Best Selling COVID-19 Vaccines and Drugs of 2020
January 2021 Vol. 41 No. 1
Seven Biopharma Trends to Watch in 2021
A-Lists
Top 15 Best-Selling Drugs Launched in 2020
A-Lists
Top 50 NIH-Funded Institutions of 2020
July 2020 Vol. 40 No. 7
Top 10 Earners among Women Biopharma Executives
Topics
All
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Infectious Diseases
SARS-CoV-2 Under Surveillance
Cancer
Immune Cell Profiles Reveal Cancer’s Leading Indicators
Translational Medicine
Animal Models Offer Improved Translatability
OMICs
Genomic Medicine Stands on the Shoulders of Giants
Magazine
Current Issue
Past Issues
Supplements
Subscribe
Resources
All
GEN Live
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Home
CRISPR/Cas9
CRISPR/Cas9
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
CRISPR/Cas9
Toxoplasmosis Vaccine for Cats Benefits from Stealthy CRISPR-Cas9 Technique
CRISPR/Cas9
Three of a Kind: New Study Grades Methods to Assess Off-Target CRISPR Edits
CRISPR/Cas9
Imbalance of Developmental Networks Leads to Congenital Heart Disease
CRISPR/Cas9
CRISPR Screen for Human Organoids Doubles Genes Linked to Microcephaly
CRISPR/Cas9
Interbacterial Toxin Leads Scientists to CRISPR-Free Method for Precise Mitochondrial Gene Editing
CRISPR/Cas9
CRISPR: A New Break in the GPCR Drug Development Pipeline
CRISPR/Cas9
Alliance Task Force Joins Consensus against Germline Gene Editing
CRISPR/Cas9
Eleventh U.S. CRISPR-Cas9 Patent Awarded to University of California, U. Vienna,...
CRISPR/Cas9
Broad Institute, UC File Motions Lists in Latest CRISPR Interference Proceeding
CRISPR/Cas9
Sigma-Aldrich Petitions for Interference Between 3 Applications, UC Patents for CRISPR...
CRISPR/Cas9
Broad Institute, MilliporeSigma to Offer Non-Exclusive Licenses to CRISPR IP
CRISPR/Cas9
Mammoth Biosciences Licenses 2 UC Patents for CRISPR-Based Diagnostic Platform
CRISPR/Cas9
CRISPR and LASER ART Eliminate HIV from Mice
CRISPR/Cas9
University of California, U. Vienna, Charpentier Awarded Fourth U.S. CRISPR-Cas9 Patent
CRISPR/Cas9
MilliporeSigma to Be Awarded First U.S. CRISPR Patent
Load more
Scroll Up
We use cookies to give you a better experience on genengnews.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS
/* The alert message box */ .alert { padding: 20px; background-color: #ff9800; /* Red */ color: white; margin-bottom: 15px; } /* The close button */ .closebtn { margin-left: 15px; color: white; font-weight: bold; float: right; font-size: 22px; line-height: 20px; cursor: pointer; transition: 0.3s; } /* When moving the mouse over the close button */ .closebtn:hover { color: black; } .td_module_flex_2 .entry-title { font-size: 17px; line-height: 20px; }
